author-photo

Saad S. Kenderian

Mayo Clinic
University of Pennsylvania

173

Papers

2440

Citations

Citation Trend

Filter By

Papers (173) Sort By

Journal Conference Others

Favorable Modulation of Chimeric Antigen Receptor T Cells Safety and Efficacy By the Non-Covalent BTK Inhibitor Vecabrutinib

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Development of a Clinically Relevant Reporter for Chimeric Antigen Receptor T-cell Expansion, Trafficking, and Toxicity.

2021 Cancer immunology research
Show All
- Source
- Cite
- Save
Citations (0)
In vivo CART Cell Imaging: Paving the Way for Success in CART Cell Therapy

2021 Molecular Therapy - Oncolytics
Show All
- Source
- Cite
- Save
Citations (2)
CRISPR Takes the Front Seat in CART-Cell Development.

2021 BioDrugs
Show All
- Source
- Cite
- Save
Citations (3)
The prognostic significance of del6q23 in chronic lymphocytic leukemia.

2021 American Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (1)
Cause of death in patients with newly diagnosed chronic lymphocytic leukemia (CLL) stratified by the CLL-International Prognostic Index.

2021 Blood Cancer Journal
Show All
- Source
- Cite
- Save
Citations (0)
CLL-376: Clinical Characteristics and Outcomes of Patients with Chronic Lymphocytic Leukemia (CLL), 80 Years of Age or Older

2021 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
Poster: CT-387: Prognostic Role of Lymphocyte to Monocyte Ratio in Pts Treated with CAR-T for Aggressive Lymphoma

2021 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
Omics analyses provide insights to CART cell therapy resistance

2021
- Michelle J. Cox
- Saad S. Kenderian
Show All
- Source
- Cite
- Save
Citations (0)
Leukemic extracellular vesicles induce chimeric antigen receptor T cell dysfunction in chronic lymphocytic leukemia.

2021 Molecular Therapy
Show All
- Source
- Cite
- Save
Citations (3)